ModeX Therapeutics nabs $168M BARDA contract as part of ‘Project Next Gen’


ModeX Therapeutics, a Natick biotech, just nabbed a $168 million government deal to create antibodies that fight Covid-19 and other potential pandemic pathogens.

Previous Five things: Q3 tech layoffs, Red Sox attendance, and healthcare innovators
Next Carolina Alarco's journey from Genzyme to founder and investor